Bioventus Inc reports results for the quarter ended in March - Earnings Summary

Bioventus

10/05/2022 15:24

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of 4
cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for earnings of
5 cents per share.
    * Revenue rose 43.4% to $117.29 million from a year ago; 
analysts
expected $117.69 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 19
cents​.
    * The mean earnings estimate of analysts had fallen by
about 67.5%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Bioventus Inc shares had fallen by 41.6% this quarter and
lost 43.1% so far this year.
    * The company reported a quarterly loss of $14.81 million.
    * Wall Street's median 12-month price target for Bioventus
Inc is
$19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 02:24 p.m.  ​All
figures in US dollars unless otherwise stated